Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-17-020590)

Filing Details

Accession Number:: 0001127602-17-020590
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-05 18:15:55
Reporting Period:: 2017-06-01

Filing Date:: 2017-06-05
Accepted Time:: 2017-06-05 18:15:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882095	Gilead Sciences Inc	GILD	Biological Products, (No Disgnostic Substances) (2836)	943047598

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1334682	H Gregg Alton	Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404	Evp Comm&Acs Ala, Corp&Med Aff	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-06-01	5,000	$65.02	107,988	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
Sale prices reported for the transactions reported here range from $65.01 to $65.05. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.